Related Experiment Video
Updated: Aug 4, 2026

03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
1.1K
[Rare side effects in management of hyperthyroidism. Case report]
Gábor Sohár1, Mónika Kovács1, Andrea Györkös1
1Belgyógyászati Osztály, Zala Megyei Kórház Zalaegerszeg.
Orvosi Hetilap
|May 24, 2016
Summary
This case study details a hyperthyroidism patient who developed vasculitis from propylthiouracil and agranulocytosis from thiamasol. Complete recovery was achieved through drug withdrawal, corticosteroids, and thyroidectomy.
Area of Science:
- Endocrinology
- Nephrology
- Rheumatology
Background:
- Hyperthyroidism management involves antithyroid drugs with potential serious side effects.
- Propylthiouracil and thiamasol are common antithyroid medications.
- Rare but severe adverse drug reactions necessitate careful patient monitoring.
Observation:
- A patient with hyperthyroidism developed propylthiouracil-induced vasculitis with renal involvement.
- The patient subsequently experienced agranulocytosis with fever after treatment with thiamasol.
- Lithium carbonate provided temporary management before thyroidectomy.
Findings:
- Withdrawal of propylthiouracil and corticosteroid therapy led to complete recovery from vasculitis.
- Thiamasol treatment resulted in a severe adverse reaction (agranulocytosis).
- Thyroidectomy was successfully performed after managing drug-induced complications.
Implications:
- This case underscores the rare but significant risks associated with antithyroid drug therapy.
- Effective management of hyperthyroidism may require multidisciplinary approaches to address complex side effects.
- Highlights the importance of vigilant monitoring for adverse drug reactions in endocrine disorders.
Related Concept Videos
Increased pulse rate
Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis IV: Nursing Management
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
